Methylene blue protects liver oxidative capacity after gut ischaemia-reperfusion in the rat

O Collange1, A-L Charles, J Bouitbir

  • 1Pôle Anesthésie, Réanimation Chirurgicale, SAMU, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Olivier.collange@chru-strasbourg.fr

Abstract

Insights

Gut ischemia/reperfusion (IR) impairs liver mitochondria function. Methylene blue (MB) treatment protected against this dysfunction, preserving oxidative activity and preventing liver damage in an animal model.

Area of Science:

  • Hepatology
  • Mitochondrial Physiology
  • Surgical Research

Background:

  • Mesenteric ischemia/reperfusion (IR) can lead to liver mitochondrial dysfunction and multiple organ failure.
  • Early detection and intervention are crucial for managing IR-induced organ damage.

Purpose of the Study:

  • To investigate if gut IR causes early impairment of liver mitochondrial oxidative activity.
  • To determine if methylene blue (MB) offers protection against gut IR-induced liver mitochondrial dysfunction.

Main Methods:

  • A controlled animal study involving rats subjected to mesenteric IR.
  • Groups included controls, gut IR, and gut IR treated with MB.
  • Assessment of liver function markers, lactate, histology, apoptosis, and liver mitochondrial respiration (state 3, complexes II-IV activity).

Main Results:

  • Gut IR significantly increased liver enzymes and lactate levels, causing intestinal damage and apoptosis.
  • Liver mitochondrial state 3 respiration decreased by 30% and respiratory chain complex activities were reduced post-IR.
  • Impaired liver mitochondrial respiration correlated with elevated blood lactate levels.
  • Methylene blue administration restored liver mitochondrial function.

Conclusions:

  • Gut IR induces early liver mitochondrial dysfunction.
  • Methylene blue (MB) demonstrates protective effects against IR-induced liver mitochondrial impairment.

Related Concept Videos